Animal experiments have further confirmed that drugs that inhibit the JAK/STAT3 signaling system can greatly reduce the population of stem cells in breast cancer, and improve the efficiency of chemotherapy (31, 32). This evidence concerns the gene STAT3 and breast carcinoma.